# American Reproductive Centers – FDA Inspection, Dec 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/american-reproductive-centers/f96b37d1-1db0-47de-b693-9a2618a1386c
Source feed: FDA_Inspections

> FDA inspection 1224796 of American Reproductive Centers, December 06, 2023. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224796
- Company Name: American Reproductive Centers
- Inspection Date: 2023-12-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1067661 - 2018-09-12
- FDA Inspection 887867 - 2014-07-17
- [FDA Inspection 799852 - 2012-08-29](https://www.keypedia.com/records/fda_inspections/american-reproductive-centers/4d95023a-8494-4ef8-b24b-7bf60738f636)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/american-reproductive-centers/5336ec5b-d154-4e10-a733-b1fe8d9d7326

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d